Also known as: Beijing Qingyi Taike Pharmaceutical Technology Co., Ltd
Highest phase reached
Phase 1
First clinical trial
Last known activity
Nov 30, 2022
No events for the selected filters.
Phase 1 (1 own, 0 via acquisition)